Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 32,439 | 24,353 | 28,966 | 15,128 | 29,783 |
Operating Income | -32,439 | -24,353 | -28,966 | -15,128 | -29,783 |
Other Income | 15 | 23 | 33 | 38 | 72 |
Pre-tax Income | -32,424 | -24,330 | -28,933 | -15,090 | -29,711 |
Net Income Continuous | -32,424 | -24,330 | -28,933 | -15,090 | -29,711 |
Net Income | $-32,424 | $-24,330 | $-28,933 | $-15,090 | $-29,711 |
EPS Basic Total Ops | -0.93 | -0.70 | -0.83 | -0.43 | -0.90 |
EPS Basic Continuous Ops | -0.93 | -0.70 | -0.83 | -0.43 | -0.90 |
EPS Diluted Total Ops | -0.93 | -0.70 | -0.83 | -0.43 | -0.90 |
EPS Diluted Continuous Ops | -0.93 | -0.70 | -0.83 | -0.43 | -0.90 |
EBITDA(a) | $-32,067 | $-23,942 | $-28,774 | $-14,996 | $-29,648 |